---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-22-124148"
form_type: "8-K"
ticker: "TLSI"
cik: "0001826667"
company_name: "TriSalus Life Sciences, Inc."
filed_at: "2022-12-02T23:59:59+00:00"
generated_at: "2026-06-21T10:23:35.592493+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# MedTech Acquisition amends $944K sponsor notes; principal waived if no business combination

## Summary
- Amended two promissory notes ($544K and $400K) to clarify principal not payable if initial business combination not completed by 24-month IPO anniversary or extended date.
- Amendment eliminates repayment obligation upon failure to close a deal; all other terms unchanged.
- Notes were issued to sponsor MedTech Acquisition Sponsor LLC for working capital.
- Amendment effective December 2, 2022; notes originally issued December 30, 2021 and January 28, 2022.

## SEC filing metadata
- accession: 0001104659-22-124148
- form_type: 8-K
- ticker: TLSI
- cik: 0001826667
- company_name: TriSalus Life Sciences, Inc.
- filed_at: 2022-12-02T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 1.01, 2.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1826667/000110465922124148/0001104659-22-124148-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1826667/000110465922124148/tm2231921d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-22-124148
- JSON: https://secwatch.observer/filing/0001104659-22-124148.json
- Plain text: https://secwatch.observer/filing/0001104659-22-124148.txt

## Key facts
- Debt Financings
  TriSalus Life Sciences, Inc. amended loan of $544,000 and $400,000 with MedTech Acquisition Sponsor LLC.
  - Instrument: loan
  - Principal: $544,000 and $400,000
  - Counterparty: MedTech Acquisition Sponsor LLC
  - Event: amendment
  source text: disclosed, on December 30, 2021 and January 28, 2022, MedTech Acquisition Corporation (the “Company”) issued an unsecured promissory note in the principal amount of $544,000 and $400,000, respectively, to the Company’s sponsor, MedTech Acquisition Sponsor LLC (the “Sponsor”), for working capital purposes. On December 2, 2022, the Company amended both
  evidence_url: https://www.sec.gov/Archives/edgar/data/1826667/000110465922124148/0001104659-22-124148-index.htm
- Material Agreements
  TriSalus Life Sciences, Inc. amended a notes offering with MedTech Acquisition Sponsor LLC (effective 2022-12-02).
  - Action: amendment
  - Agreement: notes offering
  - Counterparty: MedTech Acquisition Sponsor LLC
  - Effective: 2022-12-02
  source text: On December 2, 2022, the Company amended both promissory notes to clarify that the principal of the notes will not be payable if the Company fails to complete its initial business combination on or before the 24 month anniversary of its initial public offering or such extended date as provided in the Company's amended and restated certificate of incorporation, as amended from time to time.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1826667/000110465922124148/0001104659-22-124148-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.